| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.44M | 31.64M | 22.64M | 26.69M | 35.88M | 31.77M |
| Gross Profit | 6.20M | 4.18M | 6.85M | 3.32M | 7.41M | 6.70M |
| EBITDA | -534.00K | -7.21M | 320.00K | -6.42M | 4.46M | 3.39M |
| Net Income | -2.82M | -9.57M | -2.17M | -8.18M | -292.00K | 145.00K |
Balance Sheet | ||||||
| Total Assets | 54.90M | 53.23M | 62.23M | 69.70M | 78.61M | 72.68M |
| Cash, Cash Equivalents and Short-Term Investments | 3.00M | 5.06M | 4.97M | 3.96M | 5.58M | 8.05M |
| Total Debt | 300.00K | 267.00K | 378.00K | 321.00K | 206.00K | 1.06M |
| Total Liabilities | 10.50M | 19.50M | 16.25M | 21.58M | 22.40M | 16.19M |
| Stockholders Equity | 44.40M | 33.73M | 45.98M | 48.12M | 56.21M | 56.49M |
Cash Flow | ||||||
| Free Cash Flow | 2.09M | 1.62M | 1.23M | -1.41M | -1.60M | 5.84M |
| Operating Cash Flow | 2.13M | 1.64M | 2.30M | -74.00K | -456.00K | 6.59M |
| Investing Cash Flow | -1.05M | -1.37M | -1.07M | -1.34M | -1.15M | -737.00K |
| Financing Cash Flow | -292.00K | -185.00K | -216.00K | -200.00K | -872.00K | -1.15M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | £50.08M | -5.27 | -10.96% | ― | 6.40% | 70.78% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | £67.61M | 9.55 | -3.99% | ― | -5.43% | -292.31% | |
56 Neutral | £35.86M | -11.38 | 31.19% | ― | 25.15% | ― | |
50 Neutral | £9.53M | -1.17 | ― | ― | ― | ― | |
45 Neutral | £11.30M | -3.01 | -9.36% | ― | -7.45% | 78.23% | |
43 Neutral | £13.77M | -0.96 | -99.34% | 23.79% | 25.44% | -1877.56% |